FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

448411000001108: Cedocard Retard 20 tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16020901000001110 Cedocard Retard 20 tablets (Pfizer Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16021001000001118 Cedocard Retard 20 tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cedocard Retard 20 tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Is a Isosorbide dinitrate 20mg m/r tablet false Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Has active ingredient Osmotic diuretic false Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Has active ingredient Isosorbide dinitrate true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Is a Isosorbide dinitrate 20mg modified-release tablets true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Is a Cedocard Retard true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Has specific active ingredient Isosorbide dinitrate true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) Is a Isosorbide dinitrate 20mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cedocard Retard 20 tablets (Pfizer Ltd) 60 tablet 6 x 10 tablets Is pack of False Cedocard Retard 20 tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier
Cedocard Retard 20 tablets (Pfizer Ltd) 60 tablet 6 x 10 tablets Has AMP True Cedocard Retard 20 tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start